The EPA was pleased to join the European Parliament Public Health (SANT) Committee’s first-ever workshop on mental health in Brussels on 15 October 2026. Prof. Martina Rojnić Kuzman gave a presentation on the clinical and scientific Foundation of mental health,…
The INSERM and CNRS Programme et Équipement Prioritaire de Recherche en Psychiatrie de Précision (PEPR PROPSY) is coordinating a Policy Initiative on Precision Psychiatry, which was featured at the European Parliament on 14 October 2026. The EPA has endorsed the…
The EPA was delighted to attend the 39th ECNP Congress in Munich from 11-13 October 2026, an excellent opportunity to meet and exchange with colleagues and partners around the latest in science and treatment of brain disorders The EPA held…
The EPA is pleased to commemorate World Mental Health Day and celebrate this year’s theme: lived experiences heard: real voices, real change. Meaningful progress in psychiatric care and mental health policy relies on grounding our clinical practice in the reality…
The EPA joined the 12th European Academy of Neurology Congress, on 27-30 June 2026 in Geneva. The Association was represented in two sessions dedicated to strengthening ties between neurology and psychiatry. EPA President Prof. Andrea Fiorillo joined a special advocacy…
EPA Past President, Prof. Geert Dom, spoke at the event on the Future of the Younger Generation: How to Curb the Addiction Epidemic and Protect Europe’s Brain Capital at the European Parliament in Brussels at the Conference on 24 June…
The EPA submitted a response to the European Commission Consultation on Cardiovascular Health Checks, calling for people with severe mental illness to be explicitly recognised as a high risk population in screening programmes for cardiovascular health. People with severe mental…
The EPA was pleased to join the event on Psychedelic Research and Access in Ukraine at the European Parliament in Brussels. The event was organised by our partners at PAREA and the the MEP Action Group on Psychedelics in Healthcare,…
PsyPal, the first consortium to receive an EU clinical research grant for the study of psychedelic therapy, has published a comprehensive guidance paper to inform stakeholders across research, clinical practice, regulation, policy, advocacy, and industry. The paper outlines key considerations…
The 12th EPA Forum took place on Saturday, 28 March in Prague ahead of the 34th European Congress of Psychiatry. The event brought together perspectives from psychiatry, psychology, neurology, lived experience, informal caregivers, and health policy from the UN, EU,…